Month: February 2021

PITTSBURGH, Feb. 22, 2021 (GLOBE NEWSWIRE) — II‐VI Incorporated (Nasdaq: IIVI), a leader in engineered materials and laser optics, today announced the introduction of its ceramic YAG (yttrium aluminum garnet) platform for solid-state lasers and optical components.The growing adoption of advanced driver-assistance systems (ADAS) in next-generation vehicles is spurring the development of LiDAR systems that can provide high-resolution mapping of a vehicle’s surrounding scene, hundreds of meters away, with components that can be produced reliably, consistently, and at scale. II-VI’s new ceramic YAG is based on a proprietary production process that is more scalable than crystalline YAG. Ceramic YAG is ideal for optical windows, and II-VI’s proprietary ceramic-doping process achieves very high doping uniformity and repeatability, enabling...

AUSTIN, Texas, Feb. 22, 2021 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced the appointment of Ms. Nicole Sandford to its Board of Directors.“I am very pleased to warmly welcome Nicole to our Board of Directors. She brings to us strong regulatory leadership skills as well as a deep understanding of financial reporting and corporate governance that will be invaluable to us as we grow and take the company to new heights,” said Valerie Palmieri, President and CEO of Aspira Women’s Health Inc.Ms. Nicole Sandford noted, “I am thrilled to join this dynamic Board of accomplished leaders. I look forward to utilizing my skills and experience to help grow the company and achieve its mission to transform women’s health, starting with ovarian cancer.”About Ms....

MIAMI, Feb. 22, 2021 (GLOBE NEWSWIRE) — International Money Express, Inc. (NASDAQ: IMXI), (Intermex) (the Company) a leading money remittance services company, announced its co-branded digital service marketed by Amigo Paisano, generated impressive triple-digit remittance growth in 2020. Although Amigo Paisano’s primary country is Guatemala, they also deliver the ability to send money to 17 other countries in LATAM, as does Intermex directly.Amigo Paisano develops unique and cost-effective marketing programs to reach and grow its digital money transfer service using the co-branded Intermex digital app, computer software, quality control, and delivery systems across the LATAM countries in which Intermex operates. The partnership helps expand Intermex’s reach and expertise in the LATAM digital marketplace and enables the Company to...

Nationally Recognized Social and Criminal Justice Advocates, DeAnna R. Hoskins and Saad Soliman, Appointed  Independent DirectorsBALTIMORE MD, Feb. 22, 2021 (GLOBE NEWSWIRE) —  via NewMediaWire — Global Boatworks Holdings, Inc.(OTC: GBBT),  (“Global” or “the Company”) today announcedthat it has appointed DeAnna R. Hoskins and Saad Soliman to the Company’sboard of directors,effective  February 12, 2021. These appointments bring the Company’s total board membership to 5. “We are pleased to welcome both DeAnna Hoskins and Saad Soliman as new independent directors to the board,” said Laurin Leonard, R3 Holdings, Inc., CEO, and Co-Founder. “Both DeAnna and Saad have distinguished themselves as leading social and criminal justice reform advocates with deep policy expertise and insights gained from their years...

BASEL, Switzerland, Feb. 22, 2021 (GLOBE NEWSWIRE) — Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, invites investors and the general public to listen to webcasts at the following investor conferences:SVB Leerink 10th Annual Global Healthcare Conference on February 25, 2021 at 3:40 p.m. Eastern Time. David Marek, Chief Executive Officer of Myovant Sciences, Inc., and Frank Karbe, President and Chief Financial Officer of Myovant Sciences, Inc., will participate in a fireside chat. Management will also participate in one-on-one investor meetings on February 25.Cowen 41st Annual Health Care Conference on March 2, 2021 at 11:10 a.m. Eastern Time. Mr. Marek and Mr. Karbe will participate in a fireside chat. Management will also participate in one-on-one investor meetings on March...

FLORHAM PARK, N.J., Feb. 22, 2021 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell activating technology, and Farmacore Biotechnology today announced that Blanver Farmoquímica e Farmacêutica S.A. has joined their consortium to develop and commercialize a novel COVID-19 vaccine in Latin America.Blanver is a leading Brazilian Pharmaceutical Company focused on the development, manufacture, and commercialization of innovative pharmaceutical products. Under the terms of the agreement, São Paulo-based Blanver will manufacture, promote, distribute, and commercialize the Versamune®-based COVID-19 vaccine in Latin America. As the license holder of Versamune-CoV2-FC (PDS0203)...

CAMBRIDGE, Mass., Feb. 22, 2021 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will present the latest company overview at the SVB Leerink 10th Annual Global Healthcare Conference. The conference is being conducted in a virtual format and the presentation will take place on Thursday, February 25, 2021, at 10:00 a.m. Eastern Time.A live webcast of the presentation will be available on the Investor Relations section of the Vericel Corporation website at: http://investors.vcel.com.About Vericel CorporationVericel is a leader in advanced therapies for the sports medicine and severe burn care markets. The company markets two cell therapy products in the United States. MACI® (autologous cultured...

HAMPTON, N.J., Feb. 22, 2021 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (Nasdaq:CLDX) today announced that the Company will participate in a fireside chat at the 10th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 24, 2021 at 2:20 p.m. ET.A webcast of the presentation will be available on the “Events & Presentations” page of the “Investors & Media” section of the Celldex website. A replay will be available for fourteen days following the event.About Celldex Therapeutics, Inc.Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system...

Company AnnouncementCOPENHAGEN, Denmark; February 22, 2021 – Genmab A/S (Nasdaq: GMAB) announced today that Tahamtan Ahmadi, M.D., Ph.D., has been appointed to the newly created position of Executive Vice President and Chief Medical Officer, Head of Experimental Medicines effective March 1, 2021. Dr. Tahi Ahmadi joined Genmab in 2017 and previously served as Genmab’s Senior Vice President, Head of Oncology. In this new role, Dr. Ahmadi will lead research, discovery, regulatory and medical activities. He joins the Executive Management Team of Chief Executive Officer Dr. Jan van de Winkel, Chief Development Officer Dr. Judith Klimovsky, Chief Financial Officer Anthony Pagano, and Chief Operating Officer Anthony Mancini.Based in Genmab’s New Jersey, U.S. office, Dr. Ahmadi has been instrumental in the scale up of the fully integrated R&D...